Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

702.P1.44 Experimental Transplantation - GVHD and GVL Poster I

Saturday, December 6, 2008: 5:30 PM-7:30 PM
Hall A (Moscone Center)
Human Alloreactive CD4+ T Cells as Potent Effector Cells and Sole Mediators of Anti-Tumor Responses in a NOD/SCID Mouse Model for Human Acute Leukemia

Sanja Stevanovic*, Marieke Griffioen, PhD*, Marianke LJ Van Schie*, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD and Bart Nijmeijer, PhD

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands

MHC-Matching at 5 Loci Results in Higher Levels of Engraftment of Allogeneic Cord Blood (CB) Hematopoietic Stem Cells (HSC) Following Neonatal Transplantation

Graca Almeida-Porada, MD, PhD1, Christopher D. Porada, PhD1*, Christine LeBlanc, BS1*, Joao L. Ascensao, MD, PhD2, Ian K. McNiece, PhD3 and Esmail D. Zanjani, PhD1*

1Animal Biotechnology, University of Nevada, Reno, Reno, NV
2V.A Medical Center, Washington, DC
3University of Miami, Miami, FL

Characterization of Cytotoxic T Lymphocyte Clones Isolated from Bone Marrow Transplant Recipient with HLA-Cw-Mismatched Donor

Kyoko Sugimoto, MD*, Makoto Murata, MD, PhD*, Seitaro Terakura, MD, PhD* and Tomoki Naoe, MD, PhD

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Blocking of IL-21 Signal Attenuates Graft-Versus-Host Disease but Not Graft-Versus-Leukemia Effect in a Mouse Model

Akiko Meguro1*, Katsutoshi Ozaki1*, Iekuni Oh1*, Haruko Matsu1*, Keiko Hatanaka1*, Raine Tatara1*, Warren J Leonard2*, Kazuya Sato1 and Keiya Ozawa1

1Division of Hematology, Departiment of Medicine, Jichi Medical University, Shimotsukeshi, Japan
2Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Molecular Identification of Individual T Cell Clones Specific for Graft-Versus-Leukemia Reaction

Veronika Foltankova1*, Eva Matejkova1*, Milan Bartos2*, Milos Dendis2*, Dana Novotna1*, Jiri Mayer, MD3* and Jaroslav Michalek, MD1*

1University Cell Immunotherapy Centre, Masaryk University, Brno, Czech Republic
2Genex CZ, Brno
3Hematology/Oncology, Masaryk University Hospital, Brno, Czech Republic

Interleukin-17-Producing T Cells: A New Potential Player Mediating Graft Versus Host Pathology  In Patients Undergoing Allogeneic Stem Cell Transplantion

Erica Dander1*, Adriana Balduzzi2*, Greta Zappa1*, Paolo Perseghin3*, Giovanna Lucchini2*, Elisabetta Todisco4*, Matteo Parma5*, Ettore Biagi1*, Iolanda Di Biasio1*, Antonello Villa6*, Pamela Della Mina6*, Maddalena Migliavacca2*, Daniela Longoni2*, Attilio Rovelli2*, Andrea Biondi7* and Giovanna D'Amico1*

1Clinica Pediatrica, Università Milano-Bicocca, Centro Ricerca M. Tettamanti, Monza (Mi), Italy
2Clinica Pediatrica, Ospedale San Gerardo, Monza (Mi), Italy
3Servizio Trasfusionale, Unita` di Aferesi e Criobiologia, Ospedale San Gerardo, Monza (Mi), Italy
4Istituto Clinico Humanitas, Rozzano (Mi), Italy
5Ospedale San Gerardo, Monza (Mi), Italy
6Consorzio MIA, Università Milano/Bicocca, Monza (Mi), Italy
7M.Tettamanti Research Center, Pediatric Clinic University of Milan Bicocca, Monza, Italy

Immunomodulatory Effects of Vitamin D: Implications for the Prevention and Treatment of Graft Versus Host Disease

Jacalyn Rosenblatt, MD1*, Adam Bissonnette2*, Zekui Wu, MD2*, Baldev Vasir, PhD2*, Corrine Zarwan, MD1*, Whitney Keefe2*, Robin Joyce, MD1*, James D. Levine, MD, MS1, Brett Glotzbecker, MD1, Nataliya Rozenvayn1*, Dimitrios Tzachanis, MD1*, Vassiliki Boussiotis, MD1*, Donald Kufe, MD2* and David Avigan, MD1

1Beth Israel Deaconess Med. Ctr., Boston, MA
2Dana Farber Cancer Institute, Boston, MA

CD11b- Donor Dendritic Cells Enhance Donor T-Cells' Th1 Polarization and Graft Versus Leukemia Activity in Allogeneic Hematopoietic Stem Cell Transplantation

Jian-Ming Li, Ph.D, Kataryna A. Darlak, B.S*, Ying Lu, Ph.D*, Cynthia Giver, Ph.D*, Wayne Harris, B.S*, David L. Jaye, M.D* and Edmund Waller, M.D, Ph.D

Emory University, Winship Cancer Inst., Atlanta, GA

Donor Single Nucleotide Polymorphism in the CCR9 Gene Affects the Incidence of Acute Skin Graft-Versus-Host Disease

Yoshihiro Inamoto, MD1*, Makoto Murata, MD, PhD1*, Yachiyo Kuwatsuka, MD1*, Akane Tsujimura, MD1*, Kyoko Sugimoto, MD1*, Taku Oba, MD2*, Makoto Onizuka, MD, PhD3*, Seitaro Terakura, MD, PhD1*, Akira Katsumi, MD, PhD1*, Koichi Miyamura, MD, PhD2, Yoshihisa Kodera4* and Tomoki Naoe, MD, PhD1

1Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
3Tokai University, Isehara, Japan
4Aichi Medical University, Aichi, Japan

Methylation in the Promoter Region and Expression of FOX-P3 Correlate with Graft Versus Host Disease, Relapse and Survival after Allogeneic Stem Cell Transplantation

Cintia Manzano Gonzalez1*, Pascual Balsalobre2*, David Serrano, MD3*, Gabriela Rodriguez Macias, MD2*, Alfonso Gomez-Pineda, MD, PhD4*, Jose L. Diez-Martin, MD, PhD5 and Ismael Buno, PhD6*

1Servicio de Hematología, Hospital general universitario Gregorio Marañón, Madrid, Spain
2Servicio de Hematología, Hospital GEneral Universitario Gregorio Marañón, Madrid
3Hematology-BMT Unit, HOSPITAL GREGORIO MARAÑON, Madrid, Spain
4Servicio de HEmatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
5Chairman of Hematology, Hopital GU Gregorio Maranon, Madrid, Spain
6Servicio de Hematología, Hospital GEneral Universitario Gregorio Marañón, Madrid, Spain

*signifies non-member of ASH